BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8553686)

  • 1. A cytochrome P4502B form is the major bioactivation enzyme for the pyrrolizidine alkaloid senecionine in guinea pig.
    Chung WG; Miranda CL; Buhler DR
    Xenobiotica; 1995 Sep; 25(9):929-39. PubMed ID: 8553686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues.
    Miranda CL; Chung W; Reed RE; Zhao X; Henderson MC; Wang JL; Williams DE; Buhler DR
    Biochem Biophys Res Commun; 1991 Jul; 178(2):546-52. PubMed ID: 1907134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):229-35. PubMed ID: 9707499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Lett; 1998 Oct; 99(2):127-37. PubMed ID: 9817084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
    Chung WG; Buhler DR
    Drug Metab Dispos; 1995 Nov; 23(11):1263-7. PubMed ID: 8591728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver.
    Miranda CL; Reed RL; Guengerich FP; Buhler DR
    Carcinogenesis; 1991 Mar; 12(3):515-9. PubMed ID: 2009596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in the hepatic microsomal metabolism of the pyrrolizidine alkaloid senecionine.
    Winter CK; Segall HJ; Jones AD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):429-33. PubMed ID: 2903002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatic in vitro metabolism of the pyrrolizidine alkaloid senecionine in sheep and cattle.
    Duringer JM; Buhler DR; Craig AM
    Am J Vet Res; 2004 Nov; 65(11):1563-72. PubMed ID: 15566096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolism of the pyrrolizidine alkaloid, senecionine, in Fischer 344 and Sprague-Dawley rats.
    Chung WG; Buhler DR
    Arch Pharm Res; 2004 May; 27(5):547-53. PubMed ID: 15202562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal formation of a pyrrolic alcohol glutathione conjugate of the pyrrolizidine alkaloid senecionine.
    Reed RL; Miranda CL; Kedzierski B; Henderson MC; Buhler DR
    Xenobiotica; 1992 Nov; 22(11):1321-7. PubMed ID: 1492424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.
    Williams DE; Reed RL; Kedzierski B; Dannan GA; Guengerich FP; Buhler DR
    Drug Metab Dispos; 1989; 17(4):387-92. PubMed ID: 2571477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a newly identified isoform of cytochrome P450 responsible for 3-hydroxylation of 2,5,2',5'-tetrachlorobiphenyl in hamster liver.
    Koga N; Kikuichi-Nishimura N; Hara T; Harada N; Ishii Y; Yamada H; Oguri K; Yoshimura H
    Arch Biochem Biophys; 1995 Mar; 317(2):464-70. PubMed ID: 7893164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical characterization of a cytochrome P450 isozyme and a protein purified from liver microsomes of male guinea pigs and their roles in the oxidative metabolism of delta 9-tetrahydrocannabinol by guinea pig liver microsomes.
    Narimatsu S; Akutsu Y; Matsunaga T; Watanabe K; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1992 Apr; 43(8):1729-36. PubMed ID: 1315542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine.
    Lin G; Cui YY; Liu XQ; Wang ZT
    Chem Res Toxicol; 2002 Nov; 15(11):1421-8. PubMed ID: 12437333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes.
    Poet TS; McQueen CA; Halpert JR
    Drug Metab Dispos; 1996 Jan; 24(1):74-80. PubMed ID: 8825193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P-450-dependent nicotine oxidation by liver microsomes of guinea pigs. Immunochemical evidence with antibody against phenobarbital-inducible cytochrome P-450.
    Nakayama H; Nakashima T; Kurogochi Y
    Biochem Pharmacol; 1985 Jul; 34(13):2281-6. PubMed ID: 4015676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.